Mednax Inc Stock
Mednax Inc Stock
Currently there is a rather positive sentiment for Mednax Inc with 4 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 17 € is below the current price of 18.1 € for Mednax Inc, so the potential is actually -6.08%.
Our community identified positive and negative aspects for Mednax Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Mednax Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Mednax Inc in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mednax Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mednax Inc | - | -4.737% | -6.701% | 35.075% | 41.406% | 23.973% | -6.218% |
| Ensign Group Inc. | -1.340% | -2.614% | -4.487% | 10.370% | 17.323% | - | - |
| Amn Healthcare Svs | 2.220% | -1.429% | -4.828% | -45.669% | -39.474% | -87.103% | -75.357% |
| Chemed Corp. | 1.120% | 0.556% | -5.729% | -30.385% | -27.309% | - | - |
Comments
Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) was upgraded by analysts at Zacks Research to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) had its price target raised by analysts at Macquarie from $19.00 to $20.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MD provided by MarketBeat